Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 92.11 USD 0.36%
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Gross Profit Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Gross Profit
$735.3m
CAGR 3-Years
19%
CAGR 5-Years
10%
CAGR 10-Years
5%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Gross Profit
$2B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
2%
ICU Medical Inc
NASDAQ:ICUI
Gross Profit
$748.2m
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
17%
Align Technology Inc
NASDAQ:ALGN
Gross Profit
$2.8B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
17%
Lantheus Holdings Inc
NASDAQ:LNTH
Gross Profit
$969.6m
CAGR 3-Years
78%
CAGR 5-Years
41%
CAGR 10-Years
25%
Merit Medical Systems Inc
NASDAQ:MMSI
Gross Profit
$620.9m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

See Also

What is Haemonetics Corp's Gross Profit?
Gross Profit
735.3m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Gross Profit amounts to 735.3m USD.

What is Haemonetics Corp's Gross Profit growth rate?
Gross Profit CAGR 10Y
5%

Over the last year, the Gross Profit growth was 13%. The average annual Gross Profit growth rates for Haemonetics Corp have been 19% over the past three years , 10% over the past five years , and 5% over the past ten years .

Back to Top